Skip to search formSkip to main contentSkip to account menu

epanolol

Known as: Benzeneacetamide, N-(2-((3-(2-cyanophenoxy)-2-hydroxypropyl)amino)ethyl)-4-hydroxy-, N-(2-((3-(2-cyanophenoxy)-2-hydroxypropyl)amino)ethyl)-4-hydroxyphenylacetamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
SummaryContinuous 24-hour ECG monitoring was performed as an additional objective in 87 patients from 5 centres in the VISA 1… 
2004
2004
This double-blind, randomized parallel group study investigated the effect of 6 months β-adrenoceptor antagonist therapy with… 
2004
2004
SummaryIn 15 healthy, not specifically trained volunteers (age: 26.6±2.7 years) single equipotent doses of a selective β1-blocker… 
Review
1993
Review
1993
SummaryHypertension is due to disturbance of the complex interplay between numerous known and unknown mechanisms that normally… 
1992
1992
The effects of epanolol (a new selective beta-adrenoceptor antagonist), diltiazem and placebo were compared in a group of 16… 
1991
1991
Epanolol (200 mg once daily) was compared with nifedipine (20 mg twice daily) in a multicentre, double-blind, randomised… 
1987
1987
1987
Experiments were performed on canine and human isolated coronary arteries to characterise human coronary beta adrenoceptors and… 
1987
1987
Summary After a 2-week placebo period, 30 men, aged 60 years (mean), with mild or moderate hypertension were randomly assigned to…